PhD Nathan Yozwiak

Head of Research, Gene and Cell Therapy Institute at Mass General Brigham

Speaker

Nathan Yozwiak, PhD, is the Head of Research at the Gene and Cell Therapy Institute (GCTI) of Mass General Brigham, a translational medicine institute affiliated with Mass General Hospital and Brigham and Women’s Hospital. Dr. Yozwiak is a scientific leader with 20+ years’ experience in virology research, broadly focused on using genomics to investigate viruses for gene therapy and to understand human disease. Prior to MGB, he was the founding Director of Viral Genomics at Ring Therapeutics, a Flagship Pioneering-backed biotech, where his work uncovering commensal viruses as a novel gene delivery platform enabled fundraising >$200M in three years. Previously, he was Associate Director of Viral Genomics at the Broad Institute and the Department of Organismal and Evolutionary Biology at Harvard University, where he managed multi-site international research consortia studying virus discovery, diagnostics, and evolution. Nathan received his Ph.D. from the University of California, Berkeley and his B.S. from Johns Hopkins University.